Profiles

Keywords
Last Name
Institution

Connection

Search Results to Jeffrey Kordower

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Kordower, Jeffrey

Item TypeName
Concept Genetic Therapy
Academic Article Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.
Academic Article Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson's disease and nonhuman primate brains.
Academic Article A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
Academic Article A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.
Academic Article Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF.
Academic Article Neurotrophic factor therapy for Parkinson's disease.
Academic Article Future of cell and gene therapies for Parkinson's disease.
Academic Article Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Academic Article AAV2-Neurturin for Parkinson's Disease: What Lessons Have We Learned?
Academic Article Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.
Academic Article Introduction: gene therapy has gone from a pipe dream to clinical reality.
Academic Article GDNF family ligands: a potential future for Parkinson's disease therapy.
Academic Article Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.
Academic Article In vivo gene delivery of glial cell line--derived neurotrophic factor for Parkinson's disease.
Academic Article Trophic factor gene therapy for Parkinson's disease.
Academic Article Gene therapy for Huntington's disease.
Academic Article Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease.
Academic Article AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease.
Academic Article Gene therapy for Parkinson's disease: still a hot topic?
Academic Article Gene therapy approaches for the treatment of Parkinson's disease.
Academic Article Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration.
Academic Article Gene therapy for Parkinson's disease.
Academic Article Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point.
Academic Article Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?
Academic Article Cell transplantation and gene therapy in Parkinson's disease.
Academic Article Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease.
Academic Article Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP-treated monkeys.
Academic Article Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
Academic Article Trophic factors therapy in Parkinson's disease.
Academic Article Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapy.
Academic Article Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.
Academic Article Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
Academic Article Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with a-synucleinopathies.
Academic Article Therapeutic approaches to target alpha-synuclein pathology.
Academic Article Disease Modification Through Trophic Factor Delivery.
Academic Article Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?
Academic Article Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease.
Academic Article GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop.
Academic Article Anti-a-synuclein ASO delivered to monoamine neurons prevents a-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys.

Search Criteria
  • Genetic Therapy